- Report
- June 2025
- 88 Pages
North America
From €3070EUR$3,450USD£2,694GBP
- Report
- October 2024
- 2000 Pages
Global
From €3555EUR$3,995USD£3,120GBP
- Report
- October 2024
- 750 Pages
Global
From €3555EUR$3,995USD£3,120GBP
- Report
- August 2024
- 1000 Pages +
Global
From €3555EUR$3,995USD£3,120GBP
- Report
- January 2021
- 350 Pages
Global
From €4270EUR$4,799USD£3,748GBP
- Report
- October 2018
- 450 Pages
Global
From €3113EUR$3,499USD£2,733GBP
- Report
- April 2024
- 225 Pages
Global
From €1179EUR$1,372USD£1,000GBP
- Report
- August 2023
- 207 Pages
Global
From €4270EUR$4,799USD£3,748GBP
- Report
- March 2023
- 300 Pages
Global
From €4270EUR$4,799USD£3,748GBP
- Report
- October 2022
- 220 Pages
Global
From €4270EUR$4,799USD£3,748GBP
- Report
- April 2022
- 481 Pages
Global
From €4270EUR$4,799USD£3,748GBP
- Report
- April 2022
- 245 Pages
Global
From €4270EUR$4,799USD£3,748GBP
- Report
- August 2019
- 519 Pages
Global
From €4003EUR$4,499USD£3,514GBP
- Report
- January 2019
- 230 Pages
Global
From €3558EUR$3,999USD£3,123GBP
- Report
- June 2024
- 569 Pages
Global
From €1297EUR$1,509USD£1,100GBP
- Report
- December 2022
- 409 Pages
Global
From €1179EUR$1,372USD£1,000GBP
- Report
- October 2024
- 243 Pages
Global
From €5129EUR$5,966USD£4,350GBP
- Report
- October 2024
- 287 Pages
Global
From €5129EUR$5,966USD£4,350GBP
- Report
- October 2023
- 286 Pages
Global
From €4657EUR$5,418USD£3,950GBP
- Report
- August 2023
- 279 Pages
Global
From €4657EUR$5,418USD£3,950GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more